Temasek Holdings

Temasek Holdings, established in 1974 and based in Singapore, is an investment company managing a diversified portfolio valued at approximately S$242 billion. The firm actively invests across various sectors, including telecommunications, media and technology, financial services, transportation, consumer products, real estate, life sciences, and energy. Temasek focuses on long-term investment themes such as transforming economies, growing middle-income populations, deepening comparative advantages, and supporting emerging champions. Its investment strategy encompasses a combination of liquid assets, listed and unlisted equities, and private equity opportunities, with a notable emphasis on mid-stage technology and life sciences investments through its private equity arm, Temasek Capital Management. Furthermore, Temasek aims to be the preferred investor for companies in Singapore and internationally, reflecting its commitment to global investment opportunities.

Pradyumna Agrawal

Director

Soyoun Ahn

Managing Director, Investment (Credit and Hybrid Solutions)

Gary Ang

Managing Director, Macro Strategy

Parimal Aswani

Managing Director, Technology

Ravi Balasubramanian

Managing Director, Portfolio Development, New Energy and Industrials

Siddartha Bhattacharjee

Head of Mobility and Logistics and Managing Director of Portfolio Strategy & Risk Group

Eric Bielke

Director

Wendy Chandra

Managing Director, Technology

Yuliang Chang

Managing Director, Investment (China)

Eu Chua

Managing Director, Institutional Relations and Singapore Market

Ranjit Dandekar

Managing Director, Investment

Promit Ghosh

Managing Director

Reena Kanagasingam

Managing Director, Investment (Public Markets)

Ming Pey Lim

Chief of Staff, Executive Office, Deputy Chief Corporate Officer and Managing Director, Strategy Office

Sheau Ming Lim

Director

Paul Liu

Managing Director, Investment (Financial Services), Portfolio Strategy and Risk Group

Anuj Maheshwari

Head, Agri-Food Managing Director, Investment (Middle East and Africa)

Nicolas Meier

Managing Director, Investment (EMEA) and Director

Jingwen Miao

Managing Director, Investment (China)

Suranjan Mukherjee

Managing Director, Cross Asset Macro Portfolio and Joint Head, Public Market Investment Strategies

Jonathan Popper

Managing Director, Portfolio Development Group

Ryan Rakestraw

Director

Parangam Ray

Managing Director, Organisation and People

Pierce Scranton

Managing Director, Institutional Relations and Deputy Head, North America

Shaun Seow

Managing Director, Singapore Market and Head, Community Stewardship

Rohit Sobti

Managing Director, New Energy and Industrials

Jason Sun

Chief Representative, Beijing and Managing Director, Investment (China)

Belinda Tan

Managing Director, Finance (Financial Management)

Man-Keung Tang

Managing Director, Macro Strategy

Sulian Tay

Operating Partner

Alan Thompson

Operating Partner

Karen Toh

Managing Director, Finance (Treasury)

Damien Vacherot

Director

Benoit Valentin

Senior Managing Director EMEA and Head of Private Equity Fund Investments

Rob Williams

Managing Director, Investment (EMEA)

Ye Xu

Managing Director, Investment (China)

Past deals in Growth Stage

Foretellix

Series C in 2023
Foretellix Ltd. specializes in developing a verification framework for Intelligent Autonomous Systems, with a primary focus on Autonomous Vehicles. Founded in 2010 and based in Tel Aviv, Israel, the company provides solutions for inspecting and verifying the safety of complex automated driving systems. Foretellix has created a unique language that serves as a standard for describing scenarios related to autonomous vehicle operation. By employing a Coverage Driven Verification methodology, which has been successfully utilized in the semiconductor industry, Foretellix aims to enhance the safety verification and validation processes for Advanced Driver Assistance Systems (ADAS) and autonomous vehicles. The company's innovative approach aims to reduce risks, costs, and time to market in the rapidly evolving field of automotive technology.

Amogy

Series B in 2023
Amogy is a start-up, located in Brooklyn, New York and is working on a novel carbon-free energy storage system using ammonia as a fuel.

Ionblox

Series B in 2023
Zenlabs has developed proprietary silicon-based formulations that offer higher specific capacity, longer cycle life, and lower cost. Zenlabs' anodes are unique in their high loading level and high active silicon content. In addition, Zenlabs has solved the common problems with silicon based anodes such as poor cycling and swelling. Zenlabs combines these high capacity anodes with high capacity cathode materials in large format pouch cells to achieve energy densities that are much higher than what is commercially available.

Pasqal

Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

DotPe

Series B in 2022
DotPe is a technology start-up based in Gurgaon, Haryana, India, founded in 2019 by Anurag Gupta, Gyanesh Sharma, and Shailaz Nag. The company operates a commerce and payments platform designed to enhance customer engagement and streamline the payment experience for offline enterprises. By facilitating digital transformation, DotPe enables businesses to sell directly to consumers, manage their catalogs, and improve overall efficiency. The platform offers various features, including customer management, order management, website management, shipping and logistics, and marketing, helping offline businesses grow and adapt to modern sales strategies.

OnPoint

Series B in 2022
OnPoint is a management consulting firm based in Arlington, Virginia, specializing in delivering secure IT infrastructure and enterprise systems for the U.S. federal government. The company offers a range of technology and management consulting services, including risk management, compliance, strategic integration, security awareness training, and program management. By providing comprehensive solutions, OnPoint helps its clients effectively navigate complex challenges, from marketing and strategic communications to cybersecurity, ensuring that they receive tailored and dynamic support to meet their needs.

Jaguar Microsystems

Series B in 2022
Jaguar Microsystems is a technology company specializing in cloud computing and data processing solutions for data centers. Founded by Dr. Sunny Siu in 2020, the company develops data processing unit (DPU) chips aimed at enhancing the efficiency of data processing for its clients. Jaguar Microsystems offers products that feature accelerated Remote Direct Memory Access (RDMA) and RoCE, specifically designed for data center applications. The company targets domestic cloud service providers, telecommunications, and Internet service providers while also expanding its reach to meet the demands of the global market.

TeraWatt Technology

Series B in 2022
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, with a subsidiary in Tokyo, Japan, specializes in the design and development of lithium-ion rechargeable batteries. The company's focus is on creating batteries that combine high energy density, power density, and safety, catering to various electrified applications. By leveraging advanced engineering and production techniques, TeraWatt Technology aims to provide industrial clients with long-lasting, safe, and reliable power solutions, thereby enhancing the performance of their electrified systems.

Brightseed

Series B in 2022
Brightseed, Inc. is a biotechnology company that specializes in discovering clinically beneficial molecules found in plants through its innovative Forager platform. Founded in 2017 and based in San Francisco, California, the company employs artificial intelligence and machine learning algorithms to screen plant genes, identifying the most effective sources for addressing various health conditions. By uncovering naturally occurring compounds with potential health benefits, Brightseed aims to enhance the quality of life and support chronic disease management. The company’s mission is to strengthen the connection between people and plants, ultimately facilitating a healthier future for individuals and communities.

UPSIDE Foods

Series C in 2022
UPSIDE Foods, formerly known as Memphis Meats, is a company headquartered in San Francisco, California, that specializes in producing cultured meat directly from animal cells. Founded in 2015 by Uma Valeti and Nicholas Genovese, the company focuses on developing products such as hot dogs, sausages, burgers, and meatballs without the need to raise and slaughter animals. This innovative approach to meat production requires significantly less caloric input, water, land, and energy compared to traditional methods, while also aiming to provide consumers with cleaner meat products that are free from harmful chemicals.

Waresix

Series B in 2022
Waresix is a logistics platform for freight-forwarding, warehouse, and land transportation. It is a platform that matches unused warehouse space with users in need of such facility, looks to capitalize on the demand for flexible warehousing given the booming e-commerce market in the country. Waresix provides a solution for dynamic warehousing strategy that allows customers, retailer, distributor, and manufacturer to quickly adapt to variable demand. Waresix is headquartered in Jakarta, Indonesia.

Autobrains

Series C in 2022
Cartica’s revolutionary automotive visual intelligence platform is built on the foundation of a mature self-learning technology backed by more than 200 patents. Utilizing robust signature-based representation structures coupled with unsupervised learning methodologies, Cartica’s visual intelligence platform garners a comprehensive and detailed understanding of the vehicle’s environment.

Immutable

Series C in 2022
Immutable Pty Ltd, founded in 2018 and based in Sydney, Australia, specializes in developing video games that leverage blockchain technology. The company focuses on creating scalable infrastructure that enhances in-game economies, promoting transparency and enabling player ownership of in-game assets. Immutable provides tools and services that allow players the freedom to trade and build their gaming experiences. Originally known as Fuel Games Pty Ltd, the company emphasizes empowering players by returning control over digital assets to them.

Wildtype

Series B in 2022
Wild Type, Inc. is a San Francisco-based company that produces meat, poultry, and seafood through cellular agriculture, eliminating the need for raising or slaughtering animals. Founded in 2016, Wild Type offers a sustainable alternative to traditional food sources, addressing critical issues such as climate change, food security, and public health. By leveraging advanced cellular agriculture technologies, the company aims to redefine how society sources healthy and delicious meat, contributing to a more sustainable food ecosystem.

Amber Group

Series B in 2022
Amber Group is a prominent cryptocurrency financial services provider headquartered in Hong Kong, established in 2017 by finance professionals with backgrounds from major institutions. The company facilitates the buying and selling of cryptocurrency products and offers a range of services including yield enhancement, collateralized lending, decentralized finance, execution services, and electronic market making. Operating globally, Amber Group serves over 200 institutional clients, engaging in significant trading activity across numerous electronic exchanges with an average daily trading volume between $100 million and $200 million. The firm is dedicated to optimizing investment flexibility and maximizing returns for its clients by leveraging advanced technology and quantitative research, thereby enhancing the overall crypto finance experience. In 2019, Amber Group secured $28 million in a Series A funding round, attracting investment from notable players in the cryptocurrency sector.

Soul Machines

Series B in 2022
Soul Machines Limited specializes in creating emotionally responsive avatars that enhance user interactions with artificial intelligence platforms. Founded in 2016 and headquartered in Auckland, New Zealand, the company also operates offices in major cities including San Francisco, New York, London, Tokyo, and Melbourne. Its flagship product, Digital DNA Studio, empowers users to design custom digital personas for various applications, including customer care, marketing, education, and training. By leveraging advanced technology, Soul Machines aims to redefine customer engagement and promote deeper interactivity, ultimately transforming how individuals interact with machines and brands. The company's innovative approach focuses on creating empathetic AI assistants that facilitate meaningful human-machine collaboration, enhancing overall user experiences across multiple sectors, from retail to healthcare.

Waterdrop

Series B in 2022
Waterdrop is a producer of innovative water-based beverages designed to enhance hydration and wellness. The company offers a unique product in the form of small, sugar-free, dissolvable cubes that transform plain water into flavorful drinks. These micro drinks are enriched with vitamins and extracts sourced from high-quality natural ingredients, including fruits and plants. This approach allows consumers to enjoy a refreshing beverage without added sugars while promoting adequate hydration. Waterdrop emphasizes the use of environmentally friendly raw materials, aligning its products with sustainable practices.

FTX

Series C in 2022
FTX Trading LTD is a cryptocurrency derivatives exchange founded in 2017 and based in San Francisco, California. The platform caters to both professional traders and novices, offering features such as futures trading, leveraged tokens, and an over-the-counter portal. It supports a variety of financial products, including quarterly and perpetual futures for major cryptocurrencies like bitcoin, ether, and binance coin, as well as various altcoin and midcap indices. FTX was co-founded by Sam Bankman-Fried and Gary Wang, with initial backing from Alameda Research, which provided significant liquidity from the outset. The exchange aims to enhance the cryptocurrency trading experience and facilitate institutional adoption within the sector.

H2Pro

Series B in 2022
H2Pro, Ltd. is a company that specializes in innovative water-splitting technology aimed at producing hydrogen fuel. Founded in 2019 and based in Caesarea, Israel, H2Pro has developed a proprietary electrolysis method known as E-TAC (Electrochemical–Thermally-Activated Chemical water splitting). This technology effectively separates the hydrogen and oxygen evolution reactions, offering a super-efficient approach to green hydrogen production.

eFishery

Series C in 2022
eFishery is automatic fish feeder for all types of fish. This tool can not only provide feed scheduled, with a dose efficient, and automatic, but also record every feed in real-time. You can access the data feed, anytime, anywhere with precision. There is no longer a problem of over-feeding, fish feeding or feed irregularly diverted. eFishery provide the best solutions, reliable, and affordable.

Ola Electric

Series C in 2021
Ola Electric Mobility Pvt Limited, founded in 2017 and headquartered in Bengaluru, India, is a prominent player in the electric vehicle sector. As a subsidiary of ANI Technologies Private Limited, the company specializes in the manufacturing of electric vehicles and key components, such as battery packs, motors, and vehicle frames, at its Ola Futurefactory. Ola Electric aims to enhance electric mobility by collaborating with vehicle and battery manufacturers, cities, and driver-partners to create a comprehensive and affordable mobility ecosystem. The company not only focuses on the domestic market but is also exploring opportunities for exporting its electric vehicles to select international markets, positioning itself to capitalize on the growing demand for sustainable transportation solutions in India and beyond.

Clara Foods Co.

Series C in 2021
Clara Foods Co. specializes in producing animal-free proteins and ingredients for the food and beverage industry. Founded in 2014 and based in South San Francisco, California, the company utilizes advanced fermentation techniques to create functional and nutritional proteins derived from microorganisms. This innovative approach allows Clara Foods to offer a sustainable alternative to traditional animal agriculture, focusing on products such as baking ingredients, nutritional supplements, and egg white substitutes that are free from pathogens and salmonella. Their egg white products are particularly suited for baking applications, including cakes, meringues, and macarons. Clara Foods aims to transform the food industry by providing healthier and more humane protein sources.

Wenext

Series B in 2021
Wenext, founded in 2014, specializes in online manufacturing services tailored for makers and small to mid-size enterprises (SMEs). The company has produced over 15 million high-quality parts through its efficient digital production facilities. By offering a flexible supply chain with transparent pricing and 24-hour delivery, Wenext enhances production capacity for its clients. The platform facilitates full self-service production, significantly reducing operational costs and production time, with some orders completed in as little as one day. Wenext is ISO 9001 certified, underscoring its commitment to quality in manufacturing processes.

Commonwealth Fusion

Series B in 2021
Commonwealth Fusion Systems LLC is a research company focused on developing fusion energy as a sustainable solution to combat climate change. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes advanced rare-earth barium copper oxide superconductor technology to create energy through fusion. Commonwealth Fusion Systems combines decades of government-funded fusion research with innovative superconducting magnet technology to expedite the commercialization of fusion energy. The company emerged from the Massachusetts Institute of Technology and collaborates closely with MIT’s Plasma Science and Fusion Center, leveraging extensive research to enhance its development efforts. By designing and building fusion machines, Commonwealth Fusion aims to provide limitless and clean energy, contributing to the global transition toward sustainable energy sources.

Carro

Series C in 2021
Carro is an automotive marketplace that offers a full-stack service for all aspects of car ownership. It challenges the traditional way of buying and selling of cars through a proprietary pricing algorithm. Carro also provides a range of services that offer everything a car owner needs throughout their car ownership journeys such as an in-house financing solution warranty options and Singapore’s first on-demand roadside recovery platform. The company was founded in 2015 and is headquartered in Singapore.

RWDC Industries

Series B in 2021
RWDC Industries Ltd specializes in developing and manufacturing biodegradable bioplastics derived from medium chain length polyhydroxyalkanoate (mcl-PHA). Founded in 2015 and based in Singapore, the company produces mcl-PHA through bacterial fermentation of plant-based oils or sugars. RWDC's biopolymers are designed to serve as sustainable alternatives to conventional petroleum-based plastics, offering applications in food and beverage packaging, cutlery, drinking straws, cup lids, and even diapers. One of its notable innovations is a water-based PHA emulsion coating that can replace polyethylene in plastic-lined food packaging. The company emphasizes that its PHA is fully biodegradable in various environments, including soil and marine conditions, which positions it as a responsible choice for reducing plastic waste.

SaladStop!

Series B in 2021
SaladStop! is a pioneer in the healthy food movement in Singapore and aims to serve the best tasting and most nutritious salads, wraps and grain bowls. SaladStop! currently operates 23 outlets in Singapore and Manila and quickly approaching their vision of becoming the world’s leading nutrition, health and wellness company, expanding to Indonesia and Japan later this year.

Arbor Biotechnologies

Series B in 2021
Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.

Edge Medical Robotics

Series C in 2021
Edge Medical Robotics, Inc. is a company that specializes in designing and developing advanced surgical equipment. Founded on May 4, 2017, and based in Longgang, Shenzhen, China, the company is dedicated to researching and promoting cutting-edge medical technology. Its mission focuses on enhancing surgical safety and treatment efficacy, aiming to elevate the overall standards of healthcare. Through a commitment to excellence and precision in product development, Edge Medical Robotics strives to contribute positively to the improvement of social health outcomes.

Autobrains

Series C in 2021
Cartica’s revolutionary automotive visual intelligence platform is built on the foundation of a mature self-learning technology backed by more than 200 patents. Utilizing robust signature-based representation structures coupled with unsupervised learning methodologies, Cartica’s visual intelligence platform garners a comprehensive and detailed understanding of the vehicle’s environment.

Autobrains

Series C in 2021
Cartica’s revolutionary automotive visual intelligence platform is built on the foundation of a mature self-learning technology backed by more than 200 patents. Utilizing robust signature-based representation structures coupled with unsupervised learning methodologies, Cartica’s visual intelligence platform garners a comprehensive and detailed understanding of the vehicle’s environment.

Memed

Series C in 2021
Memed SA, founded in 2012 and based in Brazil, operates an online platform that provides e-prescription services and social collaboration tools for healthcare professionals. The platform enables doctors to create and manage digital prescriptions, facilitating effective treatment and improving patient adherence to prescribed medications. By connecting healthcare providers with key partners in the industry, Memed enhances the prescription process and supports communication among doctors, ultimately aiming to improve patient care and outcomes.

Fabric

Series C in 2021
Fabric is developing an on-demand supply chain solution aimed at grocery retailers, enabling them to provide sustainable, one-hour delivery services to their online customers. The company has created Micro-Fulfillment Centers, which are urban, automated fulfillment facilities designed to optimize local distribution while maintaining cost-efficiency. By leveraging advanced robotics and artificial intelligence, Fabric redefines the fulfillment and delivery process in urban settings. This innovative approach addresses the challenges of last-mile delivery, allowing retailers to implement true on-demand services, significantly lower operational costs, and achieve enhanced scalability in their operations.

FTX

Series B in 2021
FTX Trading LTD is a cryptocurrency derivatives exchange founded in 2017 and based in San Francisco, California. The platform caters to both professional traders and novices, offering features such as futures trading, leveraged tokens, and an over-the-counter portal. It supports a variety of financial products, including quarterly and perpetual futures for major cryptocurrencies like bitcoin, ether, and binance coin, as well as various altcoin and midcap indices. FTX was co-founded by Sam Bankman-Fried and Gary Wang, with initial backing from Alameda Research, which provided significant liquidity from the outset. The exchange aims to enhance the cryptocurrency trading experience and facilitate institutional adoption within the sector.

Orca Security

Series C in 2021
Orca Security Ltd. is a company that specializes in cloud-native security solutions, providing a platform that secures both cloud-native and legacy applications migrated to the cloud. Founded in 2019 and based in Tel Aviv, Israel, Orca's technology integrates directly into the cloud infrastructure layer, allowing for comprehensive security assessments of various assets, including the cloud control plane, operating systems, applications, and business data. The platform delivers visibility into compromised resources, vulnerable software, and misconfigurations without the need for agents, thus maintaining performance and availability. By offering cloud-wide, workload-deep security and compliance across major cloud providers like AWS, Azure, and Google Cloud, Orca Security helps organizations identify critical vulnerabilities and attack vectors efficiently, minimizing the operational costs and alert fatigue associated with traditional security tools.

Momenta

Corporate Round in 2021
Momenta is an autonomous driving startup operating out of Beijing. Its deep-learning based software in perception, HD semantic mapping, and data-driven path planning enables the realization of full autonomy. Momenta offers multi-level autonomous driving solutions as well as big data products and services. Momenta’s team is composed of some of the world’s top experts in computer vision and deep learning, including one of the authors of Faster R-CNN and ResNet, the most popular deep learning network, as well as winners of ImageNet 2015, MS COCO Challenge 2015, and ImageNet 2017. Momenta is leading the autonomous driving software space with advanced technical competence and a strong commitment to innovation.

Allay Therapeutics

Series C in 2021
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation. The company was founded in 2017 and is headquartered in Menlo Park, California, United States.
Open develops and offers an online platform for banking and intercompany settlement. It offers digital banking service for startups and small and medium enterprises that offer digital bank accounts that includes a current account packed with tools for bookkeeping, invoices, moving money, and accessing credit. Open's application programming interface platform lets financial institutions integrate banking and payments into their applications and accounting systems. Anish Achuthan founded it in 2017, with its headquarters in Bengaluru in India.

Solugen

Series C in 2021
Solugen, Inc. is a specialty chemicals manufacturer based in Houston, Texas, founded in 2016. The company utilizes industrial biotechnology and green chemistry to produce a range of eco-friendly industrial chemicals. Its product offerings include BioPeroxide, a carbon-negative hydrogen peroxide; BioChelate, a biodegradable chelant; ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, a scale control alternative to phosphonates; and CorrSol, designed for corrosion and fouling control. Solugen focuses on creating safe, cost-effective, and environmentally-friendly solutions, serving various sectors such as agriculture, cleaning, energy, and water. The company employs a patented method that leverages bio-inspired reactions and plant materials as low-cost feedstocks, enabling it to produce innovative products that are competitively priced in the market.

Solugen

Series C in 2021
Solugen, Inc. is a specialty chemicals manufacturer based in Houston, Texas, founded in 2016. The company utilizes industrial biotechnology and green chemistry to produce a range of eco-friendly industrial chemicals. Its product offerings include BioPeroxide, a carbon-negative hydrogen peroxide; BioChelate, a biodegradable chelant; ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, a scale control alternative to phosphonates; and CorrSol, designed for corrosion and fouling control. Solugen focuses on creating safe, cost-effective, and environmentally-friendly solutions, serving various sectors such as agriculture, cleaning, energy, and water. The company employs a patented method that leverages bio-inspired reactions and plant materials as low-cost feedstocks, enabling it to produce innovative products that are competitively priced in the market.

Oviva

Series C in 2021
Oviva is a digital health company providing medically-oriented nutritional counseling services in Switzerland, Germany, and the United Kingdom. Founded in 2013 and headquartered in Ingenbohl, Switzerland, Oviva offers personalized behavior change programs aimed at managing diet and lifestyle-related health issues like obesity and diabetes. Their services are delivered through a network of qualified dietitians who work with clients both in clinics and remotely. The company has developed a smartphone application that allows users to engage with their dietitian, maintain a food diary, set health goals, and access tailored educational materials. This technology-enabled approach helps patients achieve better health outcomes while reducing the need for in-person appointments, ultimately lowering healthcare costs by preventing complications associated with these conditions.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Innovusion

Series B in 2021
Innovusion, Inc. is a prominent developer of image grade LiDAR sensor systems, specifically designed for level 4 and 5 autonomous vehicles and advanced driver-assistance systems (ADAS). Founded in 2016 and based in Sunnyvale, California, Innovusion focuses on providing solutions that combine range, resolution, and hardware-accelerated sensor fusion within a compact and cost-effective framework. This unique approach makes their products suitable for the most demanding applications in the autonomous driving sector. As a venture-backed company, Innovusion is positioned at the forefront of innovation in the rapidly evolving automotive technology landscape.

Covariant

Series C in 2021
Covariant is a company focused on developing artificial intelligence for robotics. It is creating the Covariant Brain, a universal AI system that enables robots to perceive, reason, and interact with their environments. The company specializes in robotics software that utilizes deep imitation learning, deep reinforcement learning, and meta-learning techniques. This innovative approach allows clients to program robots with ease by using a virtual reality headset to guide them through specific tasks. Covariant aims to streamline the deployment of robotics across various operations, enhancing efficiency and adaptability in industrial settings.

iCapital Network

Series C in 2021
iCapital Network is an online platform that unlatches the world of private equity, enabling institutions and qualified investors. It is a financial services company that features a financial technology platform that provides modular alternative investment solutions for registered investment advisors, broker-dealers, private banks, family offices, and other sophisticated investors. The company connects advisors and their high net worth investors in leading alternative investment managers through best-in-class user experience. The company was founded in 2013 and headquartered in New York, United States.

Woebot Health

Series B in 2021
Woebot Health develops digital mental health solutions aimed at making mental health support widely accessible. Founded in 2017 and headquartered in San Francisco, the company utilizes chatbot technology to provide personalized support for mood-based disorders. Its platform integrates natural language processing with established therapeutic techniques, creating engaging interactions that deliver tailored responses to users facing specific mental health challenges. This innovative approach allows individuals to access effective mental health support conveniently, fitting seamlessly into their daily lives. Woebot Health is backed by several venture capital firms, emphasizing its commitment to advancing mental health care through technology.

FTX

Series B in 2021
FTX Trading LTD is a cryptocurrency derivatives exchange founded in 2017 and based in San Francisco, California. The platform caters to both professional traders and novices, offering features such as futures trading, leveraged tokens, and an over-the-counter portal. It supports a variety of financial products, including quarterly and perpetual futures for major cryptocurrencies like bitcoin, ether, and binance coin, as well as various altcoin and midcap indices. FTX was co-founded by Sam Bankman-Fried and Gary Wang, with initial backing from Alameda Research, which provided significant liquidity from the outset. The exchange aims to enhance the cryptocurrency trading experience and facilitate institutional adoption within the sector.

Soldo

Series C in 2021
Soldo Limited is a provider of expense management software solutions tailored for small businesses, enterprises, and accountants. Established in 2014 and based in London, with additional offices in Italy and Ireland, Soldo offers various products, including Soldo Pro, which manages expenses from payment to reconciliation, Soldo Premium for controlling business spending, and Soldo Enterprise for supporting financial strategies. The platform integrates prepaid Mastercard® cards, a web-based administration console, and a mobile app, offering a comprehensive solution to streamline the business expense cycle. This system enhances visibility and control over company spending while automating tasks and ensuring compatibility with major accounting software. Soldo has garnered significant investment, exceeding $80 million, from notable investors, reflecting its commitment to innovation in the fragmented landscape of business spending management.

Fortera

Series B in 2021
Fortera develops a process for recreating the natural material that provides significant economic savings. It Founded in 2017 and is based in Campbell, California.

Orient Speech Therapy

Series C in 2021
Provider of speech and language therapy services intended for stunted children with speech disorder. The company provides early screening, clinical diagnosis, and therapeutic interventions to children with autism or speech disorder, enabling children to speak and communicate better.

Umoja Biopharma

Series B in 2021
Provider of immunotherapies intended to transform cancer treatment and improve quality of life. The company's cellular immunotherapy platform uses gene therapy to target cancer cells and delivers to any patient, with any tumor, at any time to directly, safely, and controllably attack cancer, enabling medical practitioners to safeguard patients by creating and harnessing a powerful immune response in the body.

RecBio

Series C in 2021
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.

Helix

Series C in 2021
Helix is a prominent population genomics company that operates at the intersection of clinical care, research, and data analytics. The company provides an end-to-end platform designed to facilitate genomic research and the incorporation of genomic data into healthcare practices. Helix operates one of the largest CLIA/CAP-certified next-generation sequencing laboratories and utilizes its proprietary Exome+™ assay to support various aspects of population genomics. These include recruitment and engagement, clinically actionable disease screening, and the return of results. Additionally, Helix engages in large-scale genetic analysis and viral surveillance, delivering actionable genetic insights that aid health systems, life sciences companies, payers, and government entities in enhancing patient care and informing public health decisions.

Bowery

Series C in 2021
Bowery Farming Inc. is a modern agricultural company based in New York City, specializing in the cultivation of post-organic produce such as baby kale, lettuce, arugula, and basil. Founded in 2014, Bowery employs advanced technology, including its proprietary BoweryOS software, to create optimal growing conditions in indoor farms. This system utilizes automation, machine learning, and vision systems to monitor plant growth continuously, resulting in highly efficient farming practices. Bowery's operations use zero pesticides and consume 95% less water while achieving over 100 times the productivity of traditional farming methods on the same land area. The company sells its products through grocery stores, including select Whole Foods and Foragers locations, and supplies produce to various restaurants, including those owned by renowned chef Tom Colicchio. Bowery Farming is committed to transforming agriculture to ensure a sustainable and healthier food supply for the future.

Einride

Series B in 2021
Einride AB is a freight mobility company that specializes in the transportation of goods using innovative technologies. Founded in 2016 and headquartered in Stockholm, Sweden, with additional offices in Gothenburg and Palo Alto, Einride focuses on developing electric and autonomous logistics solutions. The company's flagship products include Einride Pods, which are electric trucks designed for transporting a variety of cargo, including pallets, timber, and perishable goods. Einride also provides clients with tools to plan, order, and track sustainable transport, aiming to redefine logistics through intelligent freight mobility solutions.

Oura

Series C in 2021
Oura is a pioneering sleep performance platform, focused on improving sleep that leads to a better life. The Oura Ring and app gives users daily feedback to improve their health, allowing users to better understand their body and reach their goals. Oura Health OyLtd. is a health technology company founded in Oulu, Finland in 2013. In 2018, the company received the Red Dot Awards for communications design and product design. Backed by world-class investors, leaders, champions, and creators, Oura Health is based in Oulu & Helsinki, Finland, and San Francisco, California.

Abiochem Biotechnology

Series C in 2021
Abiochem Biotechnology is a high-tech enterprise specializing in enzyme engineering and genetic engineering technologies. The company focuses on researching and developing biocatalytic and synthetic biology methods, which are applied to large-scale production across various sectors. Its innovations are utilized in pharmaceuticals, health care products, and pesticides, contributing to advancements in green chemistry. Abiochem Biotechnology offers customized genetic and enzyme engineering services, positioning itself as a provider of bio-intelligent manufacturing solutions for chemical and biological products.

EAVISION

Series C in 2021
EAVISION is a smart hardware company that specializes in the development and manufacturing of autonomous drones for agricultural applications. Their products incorporate advanced technologies such as artificial intelligence, autonomous driving, and machine vision, allowing for fully automated processes in plant protection, including pesticide spraying and fertilization. In addition to agricultural drones, EAVISION also offers binocular visual perception systems, AI-driven autonomous control solutions, intelligent machinery, software, and a commercial corn emasculation testing system. Through these innovations, EAVISION aims to enhance the efficiency and safety of agricultural operations. The company is also associated with a venture capital fund, focusing on investments in China.

Halodoc

Series C in 2021
PT HaloDoc is a digital healthcare platform based in Jakarta, Indonesia, founded in 2016. It connects patients with a network of 19,000 licensed doctors and 1,000 certified partner pharmacies through its services. Users can engage with medical professionals via video calls, voice calls, and chat, facilitating real-time online consultations. The platform also allows patients to order laboratory tests that can be conducted at home and helps them locate nearby hospitals and clinics. Additionally, HaloDoc provides access to licensed medical laboratory services and a medical delivery service known as ApotikAntar, further enhancing the convenience and accessibility of healthcare for its users.

Hazel Technologies

Series C in 2021
Hazel Technologies, Inc. designs and manufactures packaging inserts to reduce the spoilage of fruits and vegetables. It offers packaging inserts called sachets that are placed in boxes of the produce by growers at the time of harvest, extending the shelf-life of produce by slowing aging in produce and preventing fungus or decay. The company also provides agricultural and horticultural consulting services. Hazel Technologies, Inc. was founded in 2015 and is based in Chicago, Illinois with an additional location in Salinas, California.

Genki Forest

Venture Round in 2021
Genki Forest is a beverage company with Internet genes which specializes in making sugar-free and low-calorie products.

NewMed Medical

Series C in 2021
NewMed Medical Co., Ltd. is a Shanghai-based company focused on the research, development, manufacture, and marketing of interventional artificial heart valve systems. Established in 2015, the company specializes in producing artificial heart valves and transcather implantation systems designed to replace diseased mitral valves. These innovative products aim to simplify heart valve replacement surgery, thereby reducing treatment risks and facilitating quicker patient recovery while also lowering surgical costs. Through its advancements in medical technology, NewMed Medical contributes to improved outcomes in cardiac care.

Tezign

Series C in 2021
Tezign (Beijing) Information Technology Co., Ltd. operates Tezign.com, an Internet platform in China that provides design, creativity, marketing, and experience need services. It offers market and design services, including web/app design, graphic design, illustration, photography, creative strategy, brand strategy, e-commerce solution, event planning, and AR and VR. Tezign (Beijing) Information Technology Co., Ltd. was founded in 2014 and is based in Shanghai, China.

insitro

Series C in 2021
Insitro, Inc. is a data-driven drug discovery and development company based in South San Francisco, California, founded in 2018. The company utilizes machine learning and high-throughput biology to transform the traditional processes of drug discovery and delivery. By generating extensive functional genomic datasets and aligning them with patient data through innovative machine learning techniques, Insitro builds predictive models that aim to address critical challenges in pharmaceutical research and development. These models facilitate accelerated target selection and the design of effective therapeutics, ultimately enhancing the efficiency of drug development and informing clinical strategies. The focus of Insitro's work includes the treatment of nonalcoholic steatohepatitis (NASH), showcasing its commitment to addressing significant health issues through advanced technology.

Innovusion

Series B in 2021
Innovusion, Inc. is a prominent developer of image grade LiDAR sensor systems, specifically designed for level 4 and 5 autonomous vehicles and advanced driver-assistance systems (ADAS). Founded in 2016 and based in Sunnyvale, California, Innovusion focuses on providing solutions that combine range, resolution, and hardware-accelerated sensor fusion within a compact and cost-effective framework. This unique approach makes their products suitable for the most demanding applications in the autonomous driving sector. As a venture-backed company, Innovusion is positioned at the forefront of innovation in the rapidly evolving automotive technology landscape.

Manner

Series B in 2021
Manner Coffee operates a specialty coffee chain across several cities in China, including Shenzhen, Beijing, Chengdu, and Suzhou. Founded in 2015 and headquartered in Shanghai, the company focuses on making quality coffee accessible and affordable to a broad audience. Manner offers a diverse menu that includes coffee, tea, smoothies, juices, and desserts. In addition to beverages, the company sells coffee machines and cups. Manner is committed to environmental sustainability, incentivizing customers to bring their own reusable cups by offering a discount for each instance. This initiative reflects the company's dedication to both providing excellent coffee and promoting ecological responsibility.

Black Lake Technologies

Series C in 2021
Black Lake Technologies is an innovative company focused on transforming manufacturing through advanced mobile, IoT, and web-based collaboration platforms. These platforms enable real-time data acquisition, visualization, monitoring, and analysis, facilitating seamless communication among factory staff, from management to assembly line workers. By providing algorithm-driven and easily configurable systems, Black Lake lowers the barriers for manufacturers to adopt data analytics, fostering self-innovation and enhancing operational efficiency. The company serves a diverse clientele, including medium-sized enterprises and Fortune 500 companies, streamlining their production processes. With significant venture backing and over CNY 100 million in funding, Black Lake is well-positioned to lead the evolution of smart factories and improve manufacturing cycles.

Clover Biopharmaceuticals

Series C in 2021
Clover Biopharmaceuticals is a clinical-stage biotechnology company based in Chengdu, China, focused on discovering and developing innovative biologic therapies for cancer, autoimmune diseases, and infectious diseases. Founded in 2007, the company utilizes its proprietary Trimer-Tag technology platform to create novel biologics that target trimerization-dependent pathways. Clover also offers integrated biopharmaceutical drug manufacturing services and has in-house capabilities for cGMP biomanufacturing, which support the development of select biosimilars. Through its research and development efforts, Clover aims to bring transformative therapies to the market.

Pairwise

Series B in 2021
Pairwise is a food and technology company focused on enhancing the quality and appeal of fruits and vegetables through advanced gene-editing techniques. Founded in 2017 by a team of experts from diverse fields, Pairwise aims to create healthier and more convenient produce by developing new varieties of leafy greens, berries, and stone fruits. The company holds licenses for innovative gene-editing tools and is building an internal portfolio of traits designed to improve taste, texture, and nutritional value while also addressing environmental concerns. With a commitment to transforming dietary habits and reducing food waste, Pairwise collaborates with food and agriculture companies to deliver differentiated products that meet evolving consumer demands. The company is headquartered in San Diego, California.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Provivi

Series C in 2020
Provivi Inc. develops biopesticides for agriculture, commercial, household, and public health pest management. It develops research quantities of carbene/nitrene transferase enzymes that activate diazo and azide compounds to generate iron-carbenoids and iron-nitrenoids through a mode of activation. The company also develops a biocatalysis and fermentation technology, which is based on biocatalysts that enable efficient synthesis of biopesticides. Its technology has applications in industries, such as pharmaceuticals, nutrition, flavors, and fragrances. The company offers its products through distributors worldwide. Provivi Inc. was incorporated in 2012 and is based in Santa Monica, California.

Locanabio

Series B in 2020
Locanabio, Inc. develops RNA-targeted gene therapies to treat a spectrum of underserved diseases. It offers therapies for neuromuscular, neurodegeneration, and ophthalmology diseases. Locanabio, Inc. was formerly known as Locana, Inc. and changed its name to Locanabio, Inc. in July 2020. The company was founded in 2016 and is based in San Diego, California.

Form Energy

Series C in 2020
Form Energy, Inc. specializes in developing long-duration energy storage systems aimed at facilitating the transition from fossil fuels to renewable energy sources. The company focuses on creating low-cost battery solutions capable of storing electricity generated from wind and solar power for extended periods, thereby enhancing the reliability of the electric grid. Its core technology, which includes an innovative iron-air battery, allows for energy dispatch over multiple days, significantly improving the viability of renewable energy as a consistent power source. Founded in 2017 and headquartered in Somerville, Massachusetts, Form Energy also offers Formware, a software tool designed for capacity expansion with advanced optimization capabilities. The company's mission revolves around enabling deep decarbonization of the electric system, ultimately contributing to a more sustainable energy future. Form Energy has garnered support from various investors, including Breakthrough Energy Ventures and MIT’s The Engine.

Gracell

Series C in 2020
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering and developing innovative cell therapies for cancer treatment. The company's lead product candidates include GC012F, a dual-targeted CAR-T therapy for multiple myeloma currently in Phase I trials; GC019F, which targets adult B cell acute lymphoblastic leukemia and is also in Phase I trials; and GC007F, aimed at B cell non-Hodgkin’s lymphoma, also in Phase I. Additionally, Gracell is developing GC027, a CAR-T candidate targeting adult T cell acute lymphoblastic leukemia, and GC007g, an allogeneic CAR-T therapy for relapsed or refractory B-ALL, both in Phase I trials. Beyond these, Gracell has a pipeline of earlier-stage product candidates targeting various cancers, including ovarian and breast cancer. Founded in 2017, Gracell Biotechnologies is committed to advancing cellular therapeutics to improve patient outcomes in hematological malignancies and solid tumors.

v2food

Series B in 2020
v2food is a plant-based meat startup that produces legume-based meat alternatives. The company v2 product is a delicious, nutritious alternative for anyone who loves the taste of meat but doesn’t want to get it from animals. It is a safe space to connect with like-minded people and create positive relationships with food that will help them feed the planet in a sustainable way. v2food was founded by Nick Hazell in 2019 and is based in Sydney, New South Wales, Australia.

Nuvia

Series B in 2020
Nuvia develops processors intended to create high-performance silicon design for a compute-intensive world. It designs processing chipsets for data center servers, thereby delivering a faster, power-efficient, and secure experience to existing data center processors. Manu Gulati, John Bruno, and Gerard Williams III launched Nuvia in Santa Clara, California in 2019.

TrueLayer

Series C in 2020
TrueLayer Limited is a London-based company that offers a platform for building financial applications. Established in 2016, it provides a toolkit designed to connect to bank data, verify accounts, and access transactions in real-time. TrueLayer's software-as-a-service (SaaS) platform enables the development of various consumer and small-to-medium business applications in sectors such as payments, online lending, personal financial management, robot-advisors, insurance, investment services, peer-to-peer marketplaces, and cryptocurrencies. The company's solutions are utilized by fintech startups, online lenders, and personal finance managers, contributing to the growth of the open banking economy by facilitating the creation of innovative financial services and products.

Lu Daopei Medical Group

Series B in 2020
Lu Daopei Medical Group is a prominent healthcare provider based in Beijing, China, specializing in hematology and bone marrow transplantation. Founded in 2002, the group operates a network of hospitals that offer a range of services, including departments focused on bone marrow transplantation, general hematology, lymphoma and myeloma treatment, as well as pathology and specialty hematology laboratories. The organization is recognized for its expertise in stem cell transplantation and oncology, providing comprehensive clinical diagnosis and treatment options. Lu Daopei Medical Group aims to assist patients in navigating the complexities of their medical care, ultimately reducing their anxiety and improving treatment outcomes.

BlueVoyant

Series C in 2020
BlueVoyant is a cybersecurity company founded in 2017 and headquartered in New York, NY. It specializes in cybersecurity defense and protection by providing a blend of technology and tailored services. The company offers advanced cyber threat intelligence and managed security services, along with proactive professional services that include forensic capabilities for incident response and remediation. BlueVoyant caters to large enterprises by delivering impactful intelligence while also making its comprehensive software and services accessible to small and medium enterprises. By leveraging a world-class team of experts, BlueVoyant enhances visibility, professional insights, and targeted responsiveness in the realm of cybersecurity, ensuring robust protective measures for its clients.

Glympse Bio

Series B in 2020
Glympse Bio, Inc. is focused on developing innovative diagnostic solutions that facilitate noninvasive monitoring of various diseases, including cancer, fibrosis, immunological disorders, and infectious diseases. The company employs modular nanoparticle sensors, utilizing precisely engineered diagnostic agents that assess disease states within the body and convey this information through urine analysis. This approach allows for predictive monitoring and evaluation of treatment responses. Founded in 2015 and based in Cambridge, Massachusetts, Glympse Bio's technology is rooted in research originally conducted at MIT and led by a team of experts in nanomedicine and biomedical engineering. Their flagship product, Glympse Inside, serves as a comprehensive platform for disease monitoring and aims to revolutionize how diseases are diagnosed and managed.

Perfect Day

Series C in 2020
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

JW Therapeutics

Series B in 2020
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is relmacabtagene autoleucel, an anti-CD19 CAR-T therapy for relapsed or refractory B-cell lymphoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.

Tropic Biosciences

Series B in 2020
Tropic Biosciences UK LTD is a biotechnology company focused on developing high-performing commercial varieties of tropical crops, specifically targeting the coffee and banana industries. Established in 2016 and headquartered in Norwich, United Kingdom, the company employs advanced non-GMO gene editing technologies to enhance crop performance while promoting grower wellbeing and consumer health. Through its innovative approach, Tropic Biosciences aims to improve sustainable agricultural practices and address the challenges faced by tropical crop producers.

Genor BioPharma

Series B in 2020
Genor BioPharma Co., Ltd. is a biopharmaceutical company based in Shanghai, China, established in 2007. The company specializes in the development and commercialization of therapeutic monoclonal antibodies (mAbs) and Fc-fusion protein drugs, focusing on oncology, autoimmune diseases, and metabolic conditions. Genor BioPharma is actively advancing a diverse pipeline of over ten products, with ten candidates currently in clinical development. Its key drug candidates include GB491, an oral CDK4/6 inhibitor, GB221, a novel HER2 mAb, and geptanolimab, among others. The company aims to address significant unmet medical needs in its therapeutic areas. Genor has also formed a strategic collaboration with Ascentage Pharma to enhance its research and development capabilities.

Arterys

Series C in 2020
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.

Ascus Biosciences

Series B in 2020
Ascus Biosciences, founded in 2015 and headquartered in San Diego, California, focuses on developing a computational and genomics-based technology platform aimed at discovering and creating next-generation microbial products. The company's innovative approach leverages advanced data analysis and genomic insights to enhance the development of microbial solutions, catering to various applications in biotechnology and related fields.

Pivot Bio

Series C in 2020
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Alan

Series C in 2020
Alan is a digital health insurance platform that aims to simplify and enhance the user experience of health insurance. Established in 2016, it is notable for being the first new independent insurance provider licensed in France since 1986. The company offers a health plan designed to provide an excellent price-quality ratio for both individuals and businesses. Alan's approach focuses on making healthcare more accessible and efficient, positioning itself as a trusted service that prioritizes customer experience. The company has successfully raised over €125 million from prominent investors, further solidifying its innovative presence in the health insurance sector.

Abbisko Therapeutics

Series C in 2020
Abbisko Therapeutics Co. Ltd. discovers, develop, and manufactures immuno-oncology therapies. It offers ABSK011 and ABSK021, which are molecule inhibitors for treating hepatocellular carcinoma; and CSF1R for the treatment of solid tumors. The company also develops therapeutics for the treatment of cancer, tumor, and diabetes, metabolic diseases, liver diseases, viral infections and CNS diseases. The company was founded in 2016 and is based in is based in Shanghai, China.

ShopBack

Series B in 2020
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

Fabric

Series B in 2020
Fabric is developing an on-demand supply chain solution aimed at grocery retailers, enabling them to provide sustainable, one-hour delivery services to their online customers. The company has created Micro-Fulfillment Centers, which are urban, automated fulfillment facilities designed to optimize local distribution while maintaining cost-efficiency. By leveraging advanced robotics and artificial intelligence, Fabric redefines the fulfillment and delivery process in urban settings. This innovative approach addresses the challenges of last-mile delivery, allowing retailers to implement true on-demand services, significantly lower operational costs, and achieve enhanced scalability in their operations.

Kaishu Jianggushi

Series C in 2020
Kaishuo Jianggushi is a children's content provider. Also known as Kaishu Story, the brand is focusing on children’s stories with additional products such as audio series and online parenting courses.

UPSIDE Foods

Series B in 2020
UPSIDE Foods, formerly known as Memphis Meats, is a company headquartered in San Francisco, California, that specializes in producing cultured meat directly from animal cells. Founded in 2015 by Uma Valeti and Nicholas Genovese, the company focuses on developing products such as hot dogs, sausages, burgers, and meatballs without the need to raise and slaughter animals. This innovative approach to meat production requires significantly less caloric input, water, land, and energy compared to traditional methods, while also aiming to provide consumers with cleaner meat products that are free from harmful chemicals.

Soul Machines

Series B in 2020
Soul Machines Limited specializes in creating emotionally responsive avatars that enhance user interactions with artificial intelligence platforms. Founded in 2016 and headquartered in Auckland, New Zealand, the company also operates offices in major cities including San Francisco, New York, London, Tokyo, and Melbourne. Its flagship product, Digital DNA Studio, empowers users to design custom digital personas for various applications, including customer care, marketing, education, and training. By leveraging advanced technology, Soul Machines aims to redefine customer engagement and promote deeper interactivity, ultimately transforming how individuals interact with machines and brands. The company's innovative approach focuses on creating empathetic AI assistants that facilitate meaningful human-machine collaboration, enhancing overall user experiences across multiple sectors, from retail to healthcare.

Transcenta

Series B in 2020
Transcenta Holding Ltd. is a clinical-stage biotherapeutics company specializing in the research, development, and manufacturing of antibody-based therapeutics. Founded in 2019 and headquartered in Suzhou, China, Transcenta has additional facilities in major cities including Shanghai, Hangzhou, and Beijing, as well as in Waltham, Massachusetts, and Princeton, New Jersey. The company was formed through the merger of HJB and MabSpace Biosciences and focuses on developing innovative antibodies aimed at treating various conditions. Currently, Transcenta is advancing nine therapeutic antibody molecules targeting oncology and select non-oncology indications, including bone and kidney disorders.

Perfect Day

Series C in 2019
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

Eigen Technologies

Series B in 2019
Eigen Technologies Limited specializes in developing software for data extraction and mining, utilizing machine learning algorithms to analyze and interpret text. Founded in 2014 and headquartered in London, with an additional office in New York, the company automates the extraction and classification of information from various types of documents, enabling clients in finance, law, and professional services to make informed decisions. By employing advanced natural language processing technology, Eigen recognizes patterns within text to provide accurate answers to specific queries and classify documents based on relevant attributes. This capability allows clients to meet regulatory requirements, assess risks, and make strategic decisions regarding asset portfolios. Eigen's solutions can be deployed on-premises or in cloud environments, integrating seamlessly into existing workflows and transforming unstructured qualitative data into actionable insights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.